Home/Filings/4/0001209191-21-017201
4//SEC Filing

Goldberg John Mayer 4

Accession 0001209191-21-017201

CIK 0001671818other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:13 PM ET

Size

5.5 KB

Accession

0001209191-21-017201

Insider Transaction Report

Form 4
Period: 2021-03-01
Goldberg John Mayer
SVP, Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-01+61,06361,063 total
    Exercise: $15.85Exp: 2031-02-28Common Stock (61,063 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Oncorus, Inc.

CIK 0001671818

Entity typeother

Related Parties

1
  • filerCIK 0001826549

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:13 PM ET
Size
5.5 KB